Synergistic Pre-Clinical Activity of Combined Epigenetic Therapy with the Novel Histone Methyltransferase EZH2 Inhibitor 3-Deazaneplanocin and Histone Deacetylase Inhibitor Panobinostat against Human AML Cells.
Autor: | Fiskus, Warren *, Wang, Yongchao *, Jillella, Anand *, Ustun, Celalettin *, Johnston, Pace *, Joshi, Rajeshree *, Rao, Rekha *, Ataja, Peter *, Marquez, Victor *, Bhalla, Kapil N. |
---|---|
Zdroj: | In Blood 16 November 2008 112(11):3356-3356 |
Databáze: | ScienceDirect |
Externí odkaz: |